TFF Pharmaceuticals, Inc.

TFFP · NASDAQ
Analyze with AI
9/30/2024
6/30/2024
3/31/2024
12/31/2023
Operating Activities
Net Income-$3,545-$4,479-$5,735-$4,762
Dep. & Amort.$141$141$140$131
Deferred Tax$0$0$0-$920
Stock-Based Comp.$568$608$627$582
Change in WC-$1,767-$84$1,851$365
Other Non-Cash$2,624$560$44$391
Operating Cash Flow-$1,980-$3,253-$3,144-$4,214
Investing Activities
PP&E Inv.$0$0$0-$46
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0-$46
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$221$5,396$13$35
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$22-$1,943$889-$32
Financing Cash Flow$199$4,425$901$1
Forex Effect-$0$4-$23$12
Net Chg. in Cash-$1,781$1,175-$2,266-$4,248
Supplemental Information
Beg. Cash$4,387$3,212$5,478$9,726
End Cash$2,607$4,387$3,212$5,478
Free Cash Flow-$1,980-$3,253-$3,144-$4,260